With 19 patents held between 2002 and 2022, Cigna Corp holds the most number of Remote Patient Monitoring patents in the Chemicals sector in the Asia-Pacific region.
The second largest number of patents were held by NantWorks LLC with 14 Remote Patient Monitoring patents. The third largest number of patents were held by Nestle SA with 9 Remote Patient Monitoring patents, of which 66.7% was contributed by Nestec SA. The fourth largest number of patents were held by Abbott Laboratories with 7 Remote Patient Monitoring patents, of which 85.7% was contributed by St. Jude Medical Coordination Center BVBA. The fifth largest number of patents were held by Aquaspersions Ltd. with 4 Remote Patient Monitoring patents.
The top five patents holders, i.e., Cigna Corp, NantWorks LLC, Nestle SA, Abbott Laboratories, and Aquaspersions Ltd. , together held 53 Remote Patient Monitoring patents during the period.
Taiwan
Germany
China
United States of America
South Korea
South Korea
Saudi Arabia
China
United Kingdom
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer